Anticoccidial Drugs Market to Reach USD 257.8 Million, Globally, by 2031 at 4.2% CAGR: Allied Market Research

News provided by

Dec 06, 2022, 20:30 ET

PORTLAND, Ore., Dec. 6, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Anticoccidial Drugs Market by Drug Class (Ionophore, Synthetic Drugs), by Drug Action (Coccidiostatic, Coccidiocidal), by Animal Type (Poultry, Cattle, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global anticoccidial drugs industry was estimated at $171.3 million in 2021, and is anticipated to hit $257.8 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chains, competitive scenarios, and regional landscapes.

Determinants of growth-

Rise in the development of advanced anticoccidial drugs and surge in government initiatives for infusing awareness about coccidiosis and its medications drive the growth of the global anticoccidial drugs market. On the other hand, stringent government guidelines that restrict the usage of anticoccidial drugs in livestock and the use of alternative medicines such as vaccines and herbal medicines to treat coccidiosis impede the growth to some extent. However, availability of new products at affordable rates is anticipated to create lucrative opportunities in the industry.

Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/15213

Covid-19 scenario-

The transport or travel restrictions and several social distancing measures made it difficult for animal owners to collect the medications and treatments they need from veterinary practices. The government and other authorities imposed strict measures for containing the Covid-19 pandemic. These factors impacted the global anticoccidial drugs market.
However, the market has now recovered slowly and got back on track.

The synthetic drugs segment to rule the roost-

By drug class, the synthetic drugs segment contributed to nearly three-fifths of the global anticoccidial drugs market revenue in 2021, and is projected to dominate by 2031. Increasing use of synthetic drugs in the control & prevention of diseases and surge in the prevalence of coccidiosis diseases fuel the segment growth. The lonophore segment, simultaneosuly, would showcase the fastest CAGR of 4.5% from 2022 to 2031.

The coccidiostatic segment to maintain the highest share-

By drug action, the coccidiostatic segment garnered the highest market share in 2021, accounting for more than three-fifths of the global anticoccidial drugs market revenue. The same segment would also cite the fastest CAGR of 4.5% from 2022 to 2031. This is due to surge in adoption of drugs with coccidiostatic mode of action and rise in research & development activities for the development of coccidiostatic medicines.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/15213

The others segment dominated the market-

By animal type, the others segment garnered more than two-fifths of the global anticoccidial drugs market revenue in 2021, and is expected to rule the roost by 2031, due to rise in demand for pet animals. The cattle segment, however, would showcase the fastest CAGR of 4.6% during the forecast period.

North America grabbed the lion's share-

By region, the anticoccidial drugs market across North America held the major share in 2021, contributing to more than two-fifths of the global market revenue, owing to high prevalence of coccidiosis, increase in the number market players and surge in the population of meat producers across the region. The Asia-Pacific region, on the other hand, would cite the fastest CAGR of 5.6% during the forecast period. The presence of high populace countries such as India and China heightens the prevalence rate of coccidiosis diseases, which propels the market growth. Also, increasing number of strategies and trends adopted by the market players has supplemented the market growth.

Key players in the industry-

Boehringer Ingelheim International GmbH
Ceva sante animale
Dosh Pharmaceuticals Private Limited
Huvepharma EOOD
Merck & Co., Inc.
Zoetis Inc.
Bayer AG
Venkateshwara hatcheries Private Limited
Vetoquinol SA
Virbac SA

The report analyzes these key players in the global anticoccidial drugs market. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.

Similar Research Reports for Information, Communication and Technology:

Europe In Vitro Fertilization (IVF) Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Coronary Stents Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Precision Medicine Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Viral Vector and Plasmid DNA Manufacturing Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com